Intensity-modulated Radiotherapy Market size is anticipated to reach USD 57 Billion by the end of 2036, growing at a CAGR of 11% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of intensity-modulated radiotherapy was over USD 32 Billion. The primary driver propelling the growth of the market is the alarming surge in cancer incidence globally.
As the prevalence of cancer continues to rise, there is an escalating demand for advanced and targeted treatment modalities that can effectively combat the disease while minimizing collateral damage to healthy tissues. Cancer, being a multifaceted and complex ailment, necessitates treatment approaches that are not only potent but also precise. IMRT, with its ability to deliver highly focused and customized radiation doses to specific cancerous cells, has emerged as a pivotal solution in modern oncology. According to a report published by the World Health Organization (WHO), the global cancer burden is anticipated to increase to 29.5 million new cancer cases per year by 2040, showcasing a substantial rise from the 19.3 million new cases reported in 2020.
The rising cancer incidence underscores the critical need for advanced treatment modalities such as IMRT to meet the growing demand for precise and effective cancer care. Intensity-modulated radiotherapy is a well-established and widely used technology in the field of radiation oncology.
Additionally, IMRT is a type of advanced radiation therapy that allows for more precise targeting of cancer cells while minimizing damage to surrounding healthy tissues.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
11% |
|
Base Year Market Size (2023) |
USD 32 Billion |
|
Forecast Year Market Size (2036) |
USD 57 Billion |
|
Regional Scope |
|
Type (Fixed-Beam, Rotational)
The fixed-beam segment in the intensity-modulated radiotherapy market is estimated to gain the largest revenue share of 60% in the year 2036. One of the key growth drivers for the fixed-beam IMRT segment is its capability to provide enhanced treatment precision and target conformity. Fixed-beam IMRT allows for the precise modulation of radiation intensity from multiple fixed angles, enabling clinicians to conform the radiation dose more closely to the shape of the tumor. This accuracy is crucial in sparing surrounding healthy tissues and critical structures while effectively treating the cancerous cells.
Fixed-beam IMRT excels in treating tumors with complex shapes and irregular geometries. The technique's ability to deliver modulated radiation from multiple fixed directions facilitates the optimization of dose distribution even for challenging tumor configurations. This makes fixed-beam IMRT particularly effective in addressing cancers in anatomically intricate areas where precision is paramount.
End Users (Hospitals, Cancer Treatment Centers, Research Institutions)
The hospitals segment in the intensity-modulated radiotherapy market is expected to garner a significant share in the year 2036. Hospitals, as primary healthcare providers, are at the forefront of offering comprehensive cancer care services. The integration of IMRT within hospital settings is driven by the need to provide patients with a full spectrum of advanced treatment options. IMRT's precision and effectiveness make it a crucial component of hospitals' oncology departments, contributing to their ability to deliver holistic and state-of-the-art cancer care. The hospitals' commitment to training and developing the expertise of healthcare professionals contributes to the growth of the IMRT segment.
Hospitals invest in specialized training programs for radiation oncologists, medical physicists, and radiation therapists to ensure the safe and effective delivery of IMRT. This emphasis on continuous education supports the seamless integration of IMRT into routine clinical practice. As per a survey conducted among hospital-based radiation oncologists revealed a 45% increase in the number of professionals participating in advanced training programs focused on IMRT techniques. Furthermore, this statistic underscores hospitals' dedication to developing and maintaining expertise in the utilization of IMRT.
Our in-depth analysis of the global intensity-modulated radiotherapy market includes the following segments:
|
Type |
|
|
End User |
|
|
Application |
|
|
Radiation Type |
|
APAC Market Forecast
The intensity-modulated radiotherapy market in the Asia Pacific region is projected to hold a revenue share of 40% by the end of 2036. A crucial growth driver of IMRT market in the Asia Pacific region is the escalating incidence and prevalence of cancer. Due to the rising population and shifting demographics, there is a heightened burden of cancer cases in the region.
The growing demand for advanced and precise treatment options, such as IMRT, has become imperative in addressing this surge in cancer diagnoses. According to a report by the International Agency for Research on Cancer (IARC), the Asia Pacific region witnessed a 25% increase in new cancer cases over the past decade. This surge highlights the pressing need for advanced treatment modalities like IMRT to effectively manage and treat the growing number of cancer patients in the region.
North American Market Statistics
The intensity-modulated radiotherapy market in the North American region is projected to hold the second-largest share during the forecast period. North America places a strong emphasis on patient-centric care, with patients actively seeking advanced treatment options that offer improved outcomes and quality of life. IMRT, known for its ability to minimize side effects and spare healthy tissues, aligns with the region's commitment to providing personalized and advanced cancer care.
The collaborative efforts between research institutions and healthcare providers in North America contribute significantly to the growth of IMRT. Research initiatives, clinical trials, and collaborative studies enhance the understanding of IMRT's efficacy and broaden its applications in cancer treatment. The growing substantial investment in oncology infrastructure and the establishment of specialized treatment centers dedicated to cancer care are driving the adoption of IMRT in North America.
Key Players
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?